NCT03803371View on ClinicalTrials.gov

Bioequivalence Study of Tramadol Hydrochloride /Paracetamol Tablets Versus Ultracet Tablets

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 26, 2019

Primary Completion Date

June 28, 2019

Study Completion Date

June 28, 2019

Conditions
Healthy
Interventions
DRUG

Ultracet Tablets

Ultracet tablet (Janssen Cilag Farmacêutica Ltda) equivalent to Tramadol hydrochloride 37.5 mg/Paracetamol 325 mg

DRUG

Tramadol hydrochloride 37.5 mg/Paracetamol 325 mg tablets - tablet (Pfizer)

Tramadol hydrochloride 37.5 mg/Paracetamol 325 mg tablets (Pfizer)

Trial Locations (1)

74935-530

ICF - Instituto de Ciencias Farmaceuticas de Estudos e Pesquisas Ltda, Aparecida de Goiânia

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03803371 - Bioequivalence Study of Tramadol Hydrochloride /Paracetamol Tablets Versus Ultracet Tablets | Biotech Hunter | Biotech Hunter